Abstract:Objective To investigate the clinical efficacy of liver transplantation for liver cirrhosis and portal hypertension.Methods The clinical data of 181 patients with liver cirrhosis and portal hypertension who were admitted to the People's Hospital of Peking University from January 2000 to January 2012 were retrospectively analyzed.The efficacy of liver transplantation for liver cirrhosis and portal hypertension was investigated.The indications of liver transplantation included repeated upper gastrointestinal hemorrhage,failure of medication,surgical treatment and interventional therapy,and portal hypertension combined with hepatic functional decompensation.Orthotropic liver transplantation or piggyback liver transplantation was selected according to the condition of the patients.The pressures of the portal vein were detected before and after the transplantation of the liver graft by the manometer tube.The incidence of postoperative complications was detected.Patients were followed up regularly till December 2012.The varices and rebleeding of the esophageal veins and the survival of the patients were monitored.The survival rates was calculated using the Kaplan-Meier method,and the measurement data were analyzed using the t test.Results Of the 181 patients,65 received orthotropic liver transplantation,and 116 received piggyback liver transplantation.The operation time,volume of blood loss and anhepatic phase were (485 ± 97) minutes,(4 380 ± 1 993) mL and (56 ± 24) minutes,respectively.T tube was placed in 157 patients.The portal vein pressure was detected in 102 patients.The portal vein pressures before and after liver transplantation were (32 ± 11) cmH2O (1 cmH2O =0.098 kPa) and (21 ± 6) cmH2O,respectively.There was significant difference in the portal vein pressure before and after liver transplantation (t =2.412,P ＜ 0.05).Severe infection was detected in 23 patients,acute renal failure in 20 patients,severe abdominal bleeding in 6 patients,vascular complications in 5 patients and primary graft non-function in 2 patients after liver transplantation.A total of 181 patients were followed up for 6-131 months.One hundred and thirty-eight patients received endoscopy or upper gastrointestinal imaging at 1 year after liver transplantation.The varices were disappeared in 112 patients and alleviated in 26 patients,with the overall alleviation rate of 85.71％ (138/161).Four patients were complicated with upper gastrointestinal rebleeding within 1 year after liver transplantation,and the rebleeding rate was 3.70％ (4/108).The condition of 3 patients was alleviated by haemostatics and endoscopic treatment,and 1 patient died of liver failure caused by rebleeding.The 1-month,1-,5-year survival rates were 86.8％,84.9％ and 77.4％,respectively.Twenty-three patients died.Fifteen patients died of multi-organ dysfunction syndrome,5 died of vascular complications (2 died of hepatic artery thrombosis,2 died of portal vein thrombosis and 1 died of anastomotic stricture of vena cava),2 died of primary graft non-function,and 1 died of respiratory complications.Conclusion Liver transplantation is an efficient method for the treatment of liver cirrhosis and portal hypertension with the advantages of low rebleeding rate and ideal efficacy of reducing portal vein pressure.

Application of liver biopsy in etiological diagnosis of unexplained portal hypertension: Porto-sinusoidal vascular disease should not be ignored

Treatment Options for Portal Hypertension in the Era of Liver Transplantation

Clinical characteristics and natural history of porto‐sinusoidal vascular disease: A cohort study of 234 patients in China

Porto-Sinusoidal Vascular Disease: A New Nomenclature Different from Idiopathic Non-Cirrhotic Portal Hypertension

[Laparoscopic Splenectomy and Pericardial Devascularization for Treatment of Portal Hypertension Due to Liver Cirrhosis].

The portal hypertension syndrome: etiology, classification, relevance, and animal models

Intrinsic Causes of Nonfibrotic Portal Hypertension—A Clinicopathologic Review of 56 Patients

Portal hypertension in patients with nonalcoholic fatty liver disease: Current knowledge and challenges

Prospective evaluation of patients with non‐cirrhotic portal hypertension: A single centre study

[Clinical Characteristics of Hepatic Sinusoidal Obstruction Syndrome: Analysis of 8 Cases].

Idiopathic Noncirrhotic Portal Hypertension: An Appraisal

S4435 Obliterative Portal Venopathy: An Unusual Case of Liver Fibrosis

Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease

Clinical Analysis of Sinistral Portal Hypertension

Liver Function Reserve in Surgical Treatment of Patients with Portal Hypertension: Report of 146 Cases.

Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management

Frequency of Portal Vein Dilatation in Chronic Liver Diseased Patients through Ultrasound

Liver Pathology in Idiopathic Portal Hypertension

Invasive and Non-invasive Diagnosis of Portal Hypertension in Cirrhosis

Clinical Efficacy of Liver Transplantation for Liver Cirrhosis and Portal Hypertension

Application of Ultrasound Elastography in Assessing Portal Hypertension